A practical review of diabetes mellitus type 2 treatment in primary care
, oraz | 17 mar 2022
O artykule
Data publikacji: 17 mar 2022
Zakres stron: 14 - 23
Otrzymano: 18 cze 2021
DOI: https://doi.org/10.2478/rjim-2021-0031
Słowa kluczowe
© 2022 Justin T. Call et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
The treatment of diabetes mellitus type 2 (DM2) is becoming more complex as new medications are approved. Primary care providers must maintain their medical knowledge on emerging medications for best patient care. This review simplifies the non-insulin treatments of diabetes with an emphasis on the cardio-renal protectants, sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1).